03/19/2024
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:20 PM | Nuvectis Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2024
7:17 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:37 AM | Mosseri Marlio Charles (Filed by)
Nuvectis Pharma (Subject)
| Form SC 13G/A | |
02/06/2024
7:47 AM | Nuvectis Pharma (Subject)
Pontifax Management 4 G.P. Ltd. (0001726334) (Filed by)
| Form SC 13G | |
01/30/2024
8:01 PM | Nuvectis Pharma (Subject)
Peters Thomas Phineas (Filed by)
| Form SC 13G/A | |
01/05/2024
3:30 PM | Nuvectis Pharma (Issuer)
Shemesh Shay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
01/05/2024
3:31 PM | Nuvectis Pharma (Issuer)
Poradosu Enrique (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2023
7:39 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2023
6:45 AM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/12/2023
3:05 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2023
7:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2023
7:37 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2023
7:16 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
8:18 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
5:07 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/27/2023
5:52 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2023
3:45 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
5:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2023
7:06 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2023
7:34 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
7:30 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2023
7:00 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:03 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2023
7:04 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/06/2023
6:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2023
7:00 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
7:45 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
7:45 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
7:59 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
7:42 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:25 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:15 AM | Hoberman Kenneth (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
7:16 AM | Kaplan Matthew L. (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon to Transform U.S. Economy? (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites.
And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it. |
06/20/2023
7:16 AM | Nuvectis Pharma (Issuer)
Oliviero James F III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
3:45 PM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
5:46 AM | Mosseri Marlio Charles (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
8:28 PM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
7:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
8:29 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
6:00 AM | BENTSUR RON (Reporting)
Nuvectis Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2023
7:22 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:30 PM | Nuvectis Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2023
8:25 AM | Nuvectis Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
